News Archive

KEYNOTE-564

Immunotherapy After Kidney Cancer Surgery Improves Overall Survival

Immunotherapy After Kidney Cancer Surgery Improves Overall Survival

Adjuvant therapy| Cancer patients| Cancer Research| Clear-cell renal-cell carcinoma (ccRCC)| Dr. Toni Choueiri| immunotherapy| KEYNOTE-564| kidney cancer| New England Journal of Medicine| Overall survival| Pembrolizumab| Phase 3 trial

Recently published in the New England Journal of Medicine, findings from the pivotal phase 3 trial, KEYNOTE-564, ...

No results found.